EYE — Nova Eye Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$42.73m
- AU$44.16m
- AU$34.87m
Annual cashflow statement for Nova Eye Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.041 | 0.489 | 0.511 | 0 | 0.512 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.72 | -6.82 | -7.86 | -6.15 | -3.15 |
| Capital Expenditures | -3.72 | -0.567 | -0.449 | -0.426 | -0.388 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.819 | -0.13 | 0.124 | 0.062 | 0.025 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.54 | -0.697 | -0.325 | -0.364 | -0.363 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.402 | 6.82 | 6.91 | 5.56 | -0.657 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.8 | -0.581 | -1.27 | -1.1 | -4.09 |